| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,213,587 | 7 | 100 |
Sells | $0 | 0 | 0 |
| Hoffman Michael B | director | 7 | $2.21M | 0 | $0 | $2.21M |
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer …
Over the last 12 months, insiders at Annovis Bio, Inc. have bought $2.21M and sold $0 worth of Annovis Bio, Inc. stock.
On average, over the past 5 years, insiders at Annovis Bio, Inc. have bought $2.21M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hoffman Michael B (director) — $2.21M.
The last purchase of 76,344 shares for transaction amount of $142,779 was made by Hoffman Michael B (director) on 2026‑05‑20.
| 2026-05-20 | Hoffman Michael B | director | 76,344 0.3558% | $1.87 | $142,779 | -15.69% | ||
| 2026-04-02 | Hoffman Michael B | director | 713,800 3.594% | $2.10 | $1.5M | -23.03% | ||
| 2025-12-08 | Hoffman Michael B | director | 45,000 0.2279% | $4.31 | $193,794 | -56.05% | ||
| 2025-11-24 | Hoffman Michael B | director | 39,200 0.2144% | $4.08 | $159,886 | -53.06% | ||
| 2025-11-24 | Hoffman Michael B | director | 28,096 0.1564% | $4.15 | $116,598 | -53.06% | ||
| 2025-11-21 | Hoffman Michael B | director | 20,000 0.0937% | $3.50 | $69,900 | -49.34% | ||
| 2025-11-14 | Hoffman Michael B | director | 15,000 0.0703% | $2.11 | $31,650 | -17.73% | ||
| 2025-10-28 | Hoffman Michael B | director | 975,610 5.0805% | $2.05 | $2M | -5.24% | ||
| 2025-10-28 | Maccecchini Maria-Luisa | President & CEO | 97,561 0.508% | $2.05 | $200,000 | -5.24% | ||
| 2021-10-12 | White Mark K. | director | 5,000 0.148% | $27.40 | $137,000 | -49.71% | ||
| 2021-10-11 | Maccecchini Maria-Luisa | PRESIDENT AND CEO | 18,000 0.5368% | $27.61 | $496,980 | -49.37% | ||
| 2021-10-11 | Bruck Claudine | director | 181 0.0054% | $27.66 | $5,006 | -49.37% | ||
| 2021-08-19 | McCarthy Reid | director | 500 0.0203% | $37.61 | $18,805 | -59.74% | ||
| 2020-02-03 | McGroarty Jeffrey Brian | Chief Financial Officer | 19,500 0.1506% | $7.15 | $139,428 | -30.90% | ||
| 2020-01-31 | Maccecchini Maria-Luisa | President and CEO | 1,600 0.0104% | $6.00 | $9,600 | -23.31% | ||
| 2020-01-31 | Hoffman Michael B | 33,333 0.216% | $6.00 | $199,998 | -23.31% | |||
| 2020-01-31 | McGroarty Jeffrey Brian | Chief Financial Officer | 33,333 0.216% | $6.00 | $199,998 | -23.31% | ||
| 2020-01-31 | Whelan, Jr. Robert M. | director | 25,000 0.162% | $6.00 | $150,000 | -23.31% | ||
| 2020-01-31 | White Mark K. | director | 1,734 0.0112% | $6.00 | $10,404 | -23.31% | ||
| 2020-01-31 | Bruck Claudine | director | 800 0.0052% | $6.00 | $4,800 | -23.31% |
| Hoffman Michael B | director | 3364883 7.8842% | $3.67M | 9 | 0 | <0.0001% |
| Maccecchini Maria-Luisa | President & CEO | 1212020 2.8398% | $1.32M | 3 | 0 | <0.0001% |
| White Mark K. | director | 56177 0.1316% | $61,232.93 | 2 | 0 | <0.0001% |
| McGroarty Jeffrey Brian | Chief Financial Officer | 52833 0.1238% | $57,587.97 | 2 | 0 | |
| Whelan, Jr. Robert M. | director | 25000 0.0586% | $27,250.00 | 1 | 0 | |
| McCarthy Reid | director | 6829 0.016% | $7,443.61 | 1 | 0 | <0.0001% |
| Bruck Claudine | director | 6067 0.0142% | $6,613.03 | 2 | 0 | <0.0001% |
$2,542,362 | 111 | 11.81% | $36.83M | |
$84,911,583 | 59 | 17.82% | $37.44M | |
$103,288,323 | 51 | 4.78% | $56.52M | |
$693,326 | 47 | -16.24% | $40.24M | |
$24,478,755 | 37 | -34.59% | $53.59M |
| Increased Positions | 38 | +111.76% | 3M | +123.76% |
| Decreased Positions | 10 | -29.41% | 262,466 | -12.96% |
| New Positions | 20 | New | 2M | New |
| Sold Out Positions | 8 | Sold Out | 257,268 | Sold Out |
| Total Postitions | 62 | +82.35% | 4M | +110.79% |
| Vanguard Group Inc | $2,694.00 | 2.73% | 738,003 | +41,239 | +5.92% | 2025-09-30 |
| Susquehanna International Group, Llp | $797.00 | 0.81% | 218,421 | +53,863 | +32.73% | 2025-09-30 |
| Geode Capital Management, Llc | $672.00 | 0.68% | 184,154 | +867 | +0.47% | 2025-09-30 |
| Citadel Advisors Llc | $636.00 | 0.65% | 174,345 | +145,019 | +494.51% | 2025-09-30 |
| Northern Trust Corp | $442.00 | 0.45% | 121,060 | +61,546 | +103.41% | 2025-09-30 |
| Merit Financial Group, Llc | $297.00 | 0.3% | 81,316 | -10,000 | -10.95% | 2025-09-30 |
| Blackrock, Inc. | $294.00 | 0.3% | 80,675 | 0 | 0% | 2025-09-30 |
| Greenwich Wealth Management Llc | $173.00 | 0.18% | 47,400 | +400 | +0.85% | 2025-09-30 |
| Wescott Financial Advisory Group, Llc | $152.00 | 0.15% | 41,607 | 0 | 0% | 2025-09-30 |
| State Street Corp | $140.00 | 0.14% | 38,435 | 0 | 0% | 2025-09-30 |